Skip to main content Accessibility help
×
Home

Coverage with evidence development: A very good beginning, but much to be done. Commentary to Hutton et al.

  • Sean R. Tunis (a1) and Kalipso Chalkidou (a2)

Extract

The study by Hutton, Trueman, and Henshall provides a thoughtful and helpful set of observations about the potential benefits of linking reimbursement to requirements for further clinical research (coverage with evidence development—CED), as well as the likely challenges and obstacles to implementation. In this commentary, we will expand upon several of the key points made in their study and offer some additional suggestions for moving this policy discussion forward

Copyright

References

Hide All

KC is supported by the Commonwealth Fund, a private independent foundation based in New York City. The views presented here are those of the author and not necessarily those of the Commonwealth Fund, its directors, officers or staff.

Coverage with evidence development: A very good beginning, but much to be done. Commentary to Hutton et al.

  • Sean R. Tunis (a1) and Kalipso Chalkidou (a2)

Metrics

Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed